Correlation Between Kilitch Drugs and Indraprastha Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kilitch Drugs and Indraprastha Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kilitch Drugs and Indraprastha Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kilitch Drugs Limited and Indraprastha Medical, you can compare the effects of market volatilities on Kilitch Drugs and Indraprastha Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kilitch Drugs with a short position of Indraprastha Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kilitch Drugs and Indraprastha Medical.

Diversification Opportunities for Kilitch Drugs and Indraprastha Medical

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Kilitch and Indraprastha is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Kilitch Drugs Limited and Indraprastha Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Indraprastha Medical and Kilitch Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kilitch Drugs Limited are associated (or correlated) with Indraprastha Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Indraprastha Medical has no effect on the direction of Kilitch Drugs i.e., Kilitch Drugs and Indraprastha Medical go up and down completely randomly.

Pair Corralation between Kilitch Drugs and Indraprastha Medical

Assuming the 90 days trading horizon Kilitch Drugs is expected to generate 2.82 times less return on investment than Indraprastha Medical. But when comparing it to its historical volatility, Kilitch Drugs Limited is 1.04 times less risky than Indraprastha Medical. It trades about 0.03 of its potential returns per unit of risk. Indraprastha Medical is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  41,250  in Indraprastha Medical on August 29, 2024 and sell it today you would earn a total of  1,875  from holding Indraprastha Medical or generate 4.55% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Kilitch Drugs Limited  vs.  Indraprastha Medical

 Performance 
       Timeline  
Kilitch Drugs Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kilitch Drugs Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.
Indraprastha Medical 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Indraprastha Medical are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting fundamental indicators, Indraprastha Medical exhibited solid returns over the last few months and may actually be approaching a breakup point.

Kilitch Drugs and Indraprastha Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kilitch Drugs and Indraprastha Medical

The main advantage of trading using opposite Kilitch Drugs and Indraprastha Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kilitch Drugs position performs unexpectedly, Indraprastha Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indraprastha Medical will offset losses from the drop in Indraprastha Medical's long position.
The idea behind Kilitch Drugs Limited and Indraprastha Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum